Document is current
Any future updates will be listed below
-
Authors
Kenny, Timothy C.
Scharenberg, Samantha
Abu-Remaileh, Monther https://orcid.org/0000-0003-3772-0477
Birsoy, Kıvanç https://orcid.org/0000-0002-7579-9895
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01 DK123323-01, F32 DK127836, K99 DK140517, T32 GM007365, 5T32GM139791-03, DP-CA271386)
Michael J. Fox Foundation for Parkinson’s Research (ASAP-000463)
Beat Batten Neuronal Ceroid Lipofuscinosis (NCL) Foundation
- License Information
-
More Information
Article History
Received: 12 December 2023
Accepted: 9 December 2024
First Online: 8 January 2025
Competing interests
: M.A.-R. is a scientific advisory board member of Lycia Therapeutics. K.B. is a scientific advisor to Nanocare Pharmaceuticals and Atavistik Bio. T.C.K. and S.S. declare no interests.
